Granules India gets approval from USFDA for selling Trospium Chloride extended-release capsules

Granules India has said that it has received a nod from the US Food and Drug Administration (USFDA) for marketing Trospium Chloride extended-release capsules.

FP Trending|Apr 24, 2020, 18:58:31 IST

Granules India has said that it has received a nod from the US Food and Drug Administration (USFDA) for marketing Trospium Chloride extended-release capsules.[caption id="attachment_4159939" align="alignleft" width="380"] Representational image. Reuters.[/caption]“We are pleased to announce approval of this niche, limited competition product, which is a nice addition to our growing product portfolio in the US market,” said Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals.According to Dailymed, which is the official provider of FDA label information, the drug is used in the treatment of overactive bladder (OAB). A sudden urge to urinate that's difficult to control is the symptom of this problem.Doctors usually prescribe one 60 mg capsule of the drug daily in the morning. It should be taken with water on an empty stomach, at least one hour before a meal. The capsules are not recommended for the treatment of patients with severe renal impairment.Trospium Chloride extended-release capsules are generic version of Allergan Inc''s Sanctura XR capsules.Citing IQVIA Health, the drug firm said, “Trospium Chloride Extended-Release Capsules, 60 mg had US sales of approximately $25 million MAT for the most recent twelve months ending in February 2020.”Granules India has received a total of 26 abbreviated new drug application (ANDA) approvals from the US drug regulator.According to Moneycontrol, the drug firm’s share price witnessed a rise of six per cent in the early trade, after it received approval from the USFDA.

Stroke is rising among young adults. Doctor explains why it's happening and what you must do

Stroke is increasingly affecting adults in their 30s, 40s and 50s. Experts say unhealthy lifestyles, undiagnosed high blood pressure and delayed treatment are driving the rise in younger stroke cases

3 min read

Stroke in young adults, silent symptoms and late diagnosis: India's growing brain health challenge

Neurologists warn that stroke is increasingly affecting people in their 30s and 40s, while many brain disorders progress silently before symptoms appear. They say early diagnosis, timely referrals and healthier lifestyles are key to reducing India's growing neurological disease burden.

5 min read

Brain tumours aren't always fatal, but delayed diagnosis can be: Experts explain the key warning signs

Brain tumours are frequently mistaken for common headaches, stress or age-related cognitive changes. Doctors say recognising warning signs early and adopting a brain-healthy lifestyle can improve outcomes and reduce the risk of long-term neurological complications.

2 min read

Spices, health and the Indian plate: Why chilli can be good for you—but moderation is still key

From boosting metabolism to supporting heart health, chillies offer several surprising health benefits. But experts say the amount you eat matters, and too much spice can do more harm than good.

4 min read

Organ donation: 5 myths you need to stop believing, according to a transplant specialist

Organ donation has the power to transform and save lives, but this can happen only when myths are replaced with facts. Building awareness, having open conversations and understanding the process can help families make informed decisions.